What is Atosiban?
Atosiban is a synthetic nonpeptide desamino-oxytocin analog and a competitive vasopressin or oxytocin receptor antagonist. It is used in after assisted reproduction, preterm birth and to halt premature labour due to its ability to decrease contractions and improve uterine receptivity by reducing intracytoplasmic calcium release and downregulate prostaglandin synthesis.

Global Atosiban Market Outlook
Atosiban is a potent stimulator of myometrial contractions and plays an important role in the initiation of both term and preterm labour. Increasing incidence of preterm birth is driving the growth of the atosiban market. An increase in the incidence of multiple pregnancies, infections and chronic conditions such as diabetes and high blood pressure among pregnant women is the factor to fuel prevalence. According to the World Health Organization, every year, an estimated 15 million babies are born preterm and this figure is rising year by year. Across 184 countries, the rate of preterm birth ranges from 5% to 18% of babies born. The burden of preventing deaths and complications from preterm birth with a healthy pregnancy is high. These deaths incidence is needed to be prevented with current, cost-effective interventions. However, associated regulatory affairs, lack of hospital facilities and inadequate education about prenatal care in rural areas restrains the growth of the market. Also, atosiban is approved only in 67 countries, excluding the USA and Japan.

Global Atosiban Market Competitive Landscape
The "Global Atosiban Market" study report will provide a valuable insight with an emphasis on global market including some of the major players such Ferring Pharmaceuticals, Sun Pharma, Shanghai Soho-Yiming Pharmaceuticals, EVER Pharma, Hangzhou Longshine Bio-Tech, Cayman Chemical and Neore Pharmaceutical. Our market analysis also entails a section solely dedicated for such major players wherein our analysts provide an insight to the financial statements of all the major players, along with its product benchmarking and SWOT analysis.

Customization of the Report
• In case of any queries or customization requirements please connect with our sales team, who will ensure that your requirements are met.

1. INTRODUCTION OF GLOBAL ATOSIBAN MARKET
1.1. Overview of the Market
1.2. Scope of Report
1.3. Assumptions

2. EXECUTIVE SUMMARY

3. RESEARCH METHODOLOGY OF VERIFIED MARKET RESEARCH
3.1. Data Mining
3.2. Validation
3.3. Primary Interviews
3.4. List of Data Sources

4. GLOBAL ATOSIBAN MARKET OUTLOOK
4.1. Overview
4.2. Market Dynamics
4.2.1. Drivers
4.2.2. Restraints
4.2.3. Opportunities
4.3. Porters Five Force Model
4.4. Value Chain Analysis
5. GLOBAL ATOSIBAN MARKET, BY TYPE
5.1. Overview
5.2. Injection
5.3. Concentrate

6. GLOBAL ATOSIBAN MARKET, BY APPLICATION
6.1. Overview
6.2. Preterm Birth
6.3. Other

7. GLOBAL ATOSIBAN MARKET, BY GEOGRAPHY
7.1. Overview
7.2. North America
7.2.1. U.S.
7.2.2. Canada
7.2.3. Mexico
7.3. Europe
7.3.1. Germany
7.3.2. U.K.
7.3.3. France
7.3.4. Rest of Europe
7.4. Asia Pacific
7.4.1. China
7.4.2. Japan
7.4.3. India
7.4.4. Rest of Asia Pacific
7.5. Rest of the World
7.5.1. Latin America
7.5.2. Middle East & Africa

8. GLOBAL ATOSIBAN MARKET COMPETITIVE LANDSCAPE
8.1. Overview
8.2. Company Market Ranking
8.3. Key Development Strategies
9. COMPANY PROFILES
9.1. Ferring Pharmaceuticals
10.1.1 Overview
10.1.2 Financial Performance
10.1.3 Product Outlook
10.1.4 Key Developments
9.2. Sun Pharma
9.2.1. Overview
9.2.2. Financial Performance
9.2.3. Product Outlook
9.2.4. Key Developments
9.3. Shanghai Soho-Yiming Pharmaceuticals
9.3.1. Overview
9.3.2. Financial Performance
9.3.3. Product Outlook
9.3.4. Key Developments
9.4. EVER Pharma
9.4.1. Overview
9.4.2. Financial Performance
9.4.3. Product Outlook
9.4.4. Key Developments
9.5. Hangzhou Longshine Bio-Tech
9.5.1. Overview
9.5.2. Financial Performance
9.5.3. Product Outlook
9.5.4. Key Developments
9.6. Cayman Chemical
9.6.1. Overview
9.6.2. Financial Performance
9.6.3. Product Outlook
9.6.4. Key Developments
9.7. Neore Pharmaceutical
9.7.1. Overview
9.7.2. Financial Performance
9.7.3. Product Outlook
9.7.4. Key Developments
10. Appendix
10.1. Related Reports

2023-2028 Global and Regional Atosiban Industry Status and Prospects Professional Market Research Report Standard Version...

The global Atosiban market is expected to reach US$ XX Million by 2028, with a CAGR of XX% from 2023 to 2028, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this field evalu...

2022-2027 Global and Regional Atosiban Acetate Industry Status and Prospects Professional Market Research Report Standard Version...

The global Atosiban Acetate market is expected to reach US$ XX Million by 2027, with a CAGR of XX% from 2022 to 2027, based on HNY Research newly published report. The prime objective of this report is to provide the insights on the post COVID-19 impact which will help market players in this fie...

Europe Atosiban Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2029...

Overview of the Europe Atosiban Market:The report discusses everything a marketer requires before investing in the Europe Atosiban Market during the forecast period 2022-2029. It provides detailed insight into current trends, market shares, market size, and sales value and...

Japan Atosiban Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2029...

Overview of the Japan Atosiban Market:The report discusses everything a marketer requires before investing in the Japan Atosiban Market during the forecast period 2022-2029. It provides detailed insight into current trends, market shares, market size, and sales value and v...

South Korea Atosiban Market Size, Key Players, Research Insights, Emerging Opportunities, COVID-19 Impact and Emerging Trends By 2029...

Overview of the South Korea Atosiban Market:The report discusses everything a marketer requires before investing in the South Korea Atosiban Market during the forecast period 2022-2029. It provides detailed insight into current trends, market shares, market size, and sales...

(COVID Version) Global Atosiban Market Status (2016-2020) and Forecast (2021E-2026F) by Region, Product Type & End-Use...

Summary The report forecast global Atosiban market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021E-2026F due to coronavirus situation. The report offers detailed coverage of Atosiban industry and main market trends with impact of coronavirus. Th...

Global Atosiban Market Research Report 2022-2026...

Atosiban is an inhibitor of the hormones oxytocin and vasopressin. It is used as an intravenous medication as a labour repressant (tocolytic) to halt premature labour. In the context of China-US trade war and global economic volatility and uncertainty, it will have a big influence on this market. At...

Global Atosiban Market Research Report 2016-2026...

Summary The global Atosiban market will reach xxx Million USD in 2021 with CAGR xx% 2021-2026. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dy...

COVID-19 Global & USA Atosiban Market Research by Company, Type & Application 2015-2026...

Summary HeyReport estimates that the Atosiban market size will grow from xxx Million USD in 2020 to xxxx Million USD by 2025, and with a CAGR of xx%. The base year considered for this report is 2019, and the market forecast is projected from 2021 to 2025. In this report, HeyReport...

2021-2027 Global and Regional Atosiban Acetate Industry Production, Sales and Consumption Status and Prospects Professional Market Research Report Standard Version...

The research team projects that the Atosiban Acetate market size will grow from XXX in 2020 to XXX by 2027, at an estimated CAGR of XX. The base year considered for the study is 2020, and the market size is projected from 2020 to 2027. The prime objective of this report is to help the user ...